UnitedHealth Group tops first quarter estimates, raises guidance

Share

Empirical Financial Services Llc increased Camden Natl Corp (CAC) stake by 46.87% reported in 2016Q4 SEC filing. Insiders own 0.50% of the company shares.

With the promising Q1 results, UnitedHealth Group has raised its 2017 outlook, predicting revenues of approximately $200 billion.

Disclosure: I have no positions in UnitedHealth Group Inc. The stock now shows its YTD (Year to Date) performance of 0.99 percent while its Weekly performance value is 0.56%. 610,168 were accumulated by Sg Americas Securities Ltd. Berkshire Asset Mngmt Ltd Pa has invested 0.16% in UnitedHealth Group Inc (NYSE:UNH). Cornerstone Advisors Inc. now owns 1,594 shares of the healthcare conglomerate's stock worth $223,000 after buying an additional 748 shares during the period. Another trade for 15,000 shares valued at $2.56 million was made by HOOPER MICHELE J on Thursday, March 16.

Shares of UnitedHealth Group Inc (NYSE:UNH) opened at 168.59 on Wednesday. Employees Retirement System Of Texas acquired 19,800 shares as Unitedhealth Group Inc (UNH)'s stock rose 15.56%. The market capitalization is $162.66 billion. (NYSE:UNH) is 166.88 whilst its 200 day moving average is 157.07. The relative volume (ratio between current volume and 3-month average) is presently sitting at 0.80.

UnitedHealth said net earnings rose to US$2.17 billion, or US$2.23 per share, from US$1.61 billion, or US$1.67 per share, a year earlier. The healthcare conglomerate reported $2.37 EPS for the quarter, topping the consensus estimate of $2.17 by $0.20. With $38.9 billion, Premiums contributed to 80% of the company's consolidated revenue. UnitedHealth Group had a net margin of 3.92% and a return on equity of 21.20%.

"UnitedHealthcare served 8.7 million seniors with medical benefit products at first quarter end, growth of 12% year-over-year", the filling noted.

UnitedHealth expects full-year earnings in the range of $9.65 to $9.85 per share, with revenue expected to be $200 billion. 2 analysts recommended Overweight these shares while 0 recommended Underweight, according to FactSet data.

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 21st.

Since January 1, 0001, it had 0 insider purchases, and 9 selling transactions for $2.68 million activity. The ex-dividend date was Wednesday, March 8th.

Can anything stop UnitedHealth Group Inc (NYSE:UNH)? You have now viewed your allowance of free articles.

Deutsche Bank Initiated its coverage for UnitedHealth Group Incorporated (UNH) in a note sent to investors on 5-Apr-17. Argus reiterated a "buy" rating and issued a $170.00 target price on shares of UnitedHealth Group in a research report on Monday, January 23rd.

Unitedhealth Group Inc. has 951,165,000 shares now held by shareholders which now trade around the 167.18 mark which totals Unitedhealth Group Inc.'s market capitalisation to 159.02B United States dollars. Strs Ohio reported 0.85% of its portfolio in UnitedHealth Group Inc (NYSE:UNH). One analyst has rated the stock with a hold rating and twenty-two have issued a buy rating to the stock. The stock tapped a 52-week high of US$76.54 while the mean 12-month price target for the shares is US$72.91. The Burney Co holds 149,823 shares with $23.98M value, down from 156,459 last quarter. The company is estimating to achieve earnings per share (EPS) growth of 14.00% in this year and the earnings per share (EPS) growth expected to be 7.32% in the next year. Guardian Capital LP now owns 70,842 shares of the healthcare conglomerate's stock valued at $11,338,000 after buying an additional 11,097 shares during the period. The share price is now up 5.33% for the past three months. The company has its outstanding Shares of 964.85 Million. Also, Director William C. Ballard, Jr. sold 5,000 shares of the firm's stock in a transaction dated Tuesday, February 14th.

Because there's no indication of what Congress plans for the tax, UnitedHealth incorporating it into its 2018 pricing models and Medicare benefits packages. Segment revenues grew nearly 8% y-o-y, but operating income grew about 16% driven by growth across all three sub-segments - OptumHealth, OptumInsight, and OptumRx.

Share